EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a dose-dependent, antigen-specific immune...
Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14 )
Also on site :
- Israel strikes Syria again, claims to have killed alleged Hamas member
- 'Full House' Star, 43, Makes Rare Comment About Ashley Olsen
- '90s Rapper and Actor, 61, Makes Rare Red Carpet Appearance